Coadministration of orally inhaled fluticasone propionate and oral ketoconazole resulted in a 1.9-fold increase in plasma fluticasone propionate exposure and a 45% decrease in plasma cortisol area ...
News Medical on MSN12d
Study finds no clinical advantage of budesonide inhaler over fluticasone in COPDA study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...
Coadministration of orally inhaled fluticasone propionate and oral ketoconazole resulted in a 1.9-fold increase in plasma fluticasone propionate exposure and a 45% decrease in plasma cortisol area ...
Subjects were then randomised to receive either an extra inhalation of the same ... muscle cramps and headache) and fluticasone propionate-related events (oral candidiasis and hoarseness) occurred ...
Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...
a twice-daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score ...
In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...
Treatment with oral or inhaled corticosteroids is not warranted ... with histories suggestive of viral-induced wheeze received high-dose fluticasone (750 µg twice daily) or placebo at the onset ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback